BIOTIME 8-K OCT 15 2009

Company

Lineage Cell Therapeutics, Inc.

Filed

October 20, 2009

Period of Report

October 15, 2009

Accession Number

0000876343-09-000066

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →